Z 300 (Vandetanib 300 mg)

Pill imprint Z 300 has been identified as Vandetanib 300 mg.

Vandetanib is used in the treatment of thyroid cancer and belongs to the drug classes EGFR inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Vandetanib 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Z 300

Vandetanib 300 mg Z 300
Vandetanib
Imprint:
Z 300
Strength:
300 mg
Color:
White
Shape:
Oval
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Astra-Zeneca Pharmaceuticals

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)